Scarica l'app Stockscreener
86.82
2.49%
2.11
Pre-mercato:
87.04
0.22
+0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$84.71
Aprire:
$84.655
Volume 24 ore:
3.16M
Relative Volume:
0.70
Capitalizzazione di mercato:
$50.38B
Reddito:
$5.88B
Utile/perdita netta:
$1.34B
Rapporto P/E:
36.96
EPS:
2.3489
Flusso di cassa netto:
$799.60M
1 W Prestazione:
+3.31%
1M Prestazione:
+14.09%
6M Prestazione:
+15.78%
1 anno Prestazione:
+21.82%
Intervallo 1D:
$84.66
$86.94
Intervallo di 1 settimana:
$83.32
$86.94
Portata 52W:
$65.94
$87.20
Edwards Lifesciences Corp Stock (EW) Company Profile
Nome
Edwards Lifesciences Corp
Settore
Industria
Telefono
(949) 250-2500
Indirizzo
ONE EDWARDS WAY, IRVINE, CA
Confronta EW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
86.82 | 49.16B | 5.88B | 1.34B | 799.60M | 2.3489 |
|
ABT
Abbott Laboratories
|
128.05 | 221.17B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
101.36 | 145.34B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
375.08 | 141.58B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.35 | 132.37B | 34.76B | 4.79B | 5.21B | 3.7049 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-10-29 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-29 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-04-24 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Stifel | Hold → Buy |
| 2025-01-16 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-11 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-09-18 | Downgrade | Jefferies | Buy → Hold |
| 2024-07-31 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-07-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | Downgrade | TD Cowen | Buy → Hold |
| 2024-07-25 | Downgrade | Truist | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-03-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-02-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2023-11-28 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | Downgrade | Bernstein | Outperform → Underperform |
| 2023-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | Downgrade | Stifel | Buy → Hold |
| 2022-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-10-26 | Iniziato | Mizuho | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-29 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-27 | Reiterato | Citigroup | Buy |
| 2022-01-27 | Reiterato | Evercore ISI | Outperform |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | Stifel | Buy |
| 2022-01-27 | Reiterato | UBS | Neutral |
| 2021-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-12-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-30 | Reiterato | Deutsche Bank | Hold |
| 2021-07-30 | Reiterato | Jefferies | Buy |
| 2021-07-30 | Reiterato | Morgan Stanley | Overweight |
| 2021-07-30 | Reiterato | Oppenheimer | Outperform |
| 2021-07-30 | Reiterato | Stifel | Buy |
| 2021-07-30 | Reiterato | UBS | Neutral |
| 2021-07-30 | Reiterato | Wells Fargo | Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-04-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-11 | Reiterato | Canaccord Genuity | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Underperform |
| 2020-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Outperform |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-10-24 | Reiterato | Canaccord Genuity | Buy |
| 2019-09-23 | Iniziato | Piper Jaffray | Overweight |
| 2019-07-24 | Reiterato | BofA/Merrill | Buy |
| 2019-03-18 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Hold |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-10-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | Downgrade | Guggenheim | Buy → Neutral |
Mostra tutto
Edwards Lifesciences Corp Borsa (EW) Ultime notizie
Edwards Lifesciences (EW) Analyst Rating Reiterates Buy with $10 - GuruFocus
Journey Strategic Wealth LLC Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Rhumbline Advisers Sells 34,159 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Mediolanum International Funds Ltd - MarketBeat
Edwards Lifesciences Corporation (EWLS.VI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Swiss National Bank Raises Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Handelsbanken Fonder AB Buys 139,909 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
DNB Asset Management AS Reduces Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Prudential PLC Has $9.36 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
SG Americas Securities LLC Decreases Position in Edwards Lifesciences Corporation $EW - MarketBeat
Howe & Rusling Inc. Has $6.64 Million Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
GDS Wealth Management Increases Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Is Edwards Lifesciences Corporation (EWL) stock a top dividend aristocrat candidateFed Meeting & Reliable Price Action Trade Plans - newser.com
Edwards Lifesciences Corporation $EW Shares Sold by Nomura Asset Management Co. Ltd. - MarketBeat
Vanguard Group Inc. Grows Position in Edwards Lifesciences Corporation $EW - MarketBeat
Will Edwards Lifesciences Corporation (EWL) stock rise with strong economyJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
Primecap Management Co. CA Acquires 1,147,291 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Highview Capital Management LLC DE Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Stock Holdings Cut by Intech Investment Management LLC - MarketBeat
Why Edwards Lifesciences Corporation stock remains a top recommendationJuly 2025 Outlook & Daily Momentum Trading Reports - newser.com
Tick level data insight on Edwards Lifesciences Corporation volatilityTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
Why Edwards Lifesciences Corporation stock attracts HNW investors2025 Risk Factors & Safe Capital Allocation Plans - newser.com
Is Edwards Lifesciences Corporation (EWL) stock positioned for secular growthMarket Trend Review & Free Daily Entry Point Trade Alerts - newser.com
What is the fair value estimate for Edwards Lifesciences Corporation (EWL) stock in 2025Market Rally & Weekly High Return Opportunities - newser.com
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Can Edwards Lifesciences Corporation (EWL) stock sustain free cash flowPortfolio Update Report & Growth Oriented Trade Recommendations - newser.com
Why Edwards Lifesciences Corporation (EWL) stock stays on top picksPortfolio Risk Summary & Short-Term Swing Trade Alerts - newser.com
Philips, Edwards team on AI-based guide for mitral valve repair - MedTech Dive
What does recent volatility data suggest for Edwards Lifesciences CorporationPortfolio Return Report & Safe Entry Zone Identification - newser.com
Edwards Lifesciences stock rating reiterated at Overweight by Piper Sandler - Investing.com India
How Edwards Lifesciences Corporation stock trades after rate cutsJobs Report & AI Forecast Swing Trade Picks - newser.com
Edwards Lifesciences Corporation $EW Shares Sold by Thoroughbred Financial Services LLC - MarketBeat
Edwards Lifesciences Corporation $EW Shares Acquired by Citigroup Inc. - MarketBeat
What consensus target says about Edwards Lifesciences Corporation stockMarket Sentiment Report & AI Forecast Swing Trade Picks - newser.com
Is Edwards Lifesciences Corporation (EWL) stock a safe buy pre earnings - newser.com
Published on: 2025-11-17 10:29:32 - newser.com
Why Edwards Lifesciences Corporation (EWL) stock stays resilient2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Ontario Teachers Pension Plan Board Raises Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Is Edwards Lifesciences Corporation stock trading at attractive multiplesPortfolio Value Report & Risk Controlled Daily Trade Plans - newser.com
Edwards Lifesciences’ PROGRESS Trial: A Game-Changer in Aortic Stenosis Treatment? - MSN
Edwards Lifesciences’s SWOT analysis: strong TAVR growth drives stock outlook - Investing.com
Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors - MarketWatch
Published on: 2025-11-17 11:56:48 - newser.com
Edwards Lifesciences Corporation $EW Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $11.25 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Creative Planning Buys 15,336 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation stock trend forecastPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
WealthShield Partners LLC Buys New Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp Azioni (EW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.20%
0.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):